Conference
Remission of type 2 diabetes following intensive treatment with insulin glargine/lixisenatide, metformin and lifestyle approaches: results of the REMIT-iGlarLixi trial
Authors
McInnes N; Hall S; Lochnan H; Harris S; Punthakee Z; Sigal RJ; Hramiak I; Azharuddin M; Liutkus J; Yale J-F
Volume
64
Pagination
pp. 224-224
Publisher
SPRINGER
Publication Date
September 2021
Conference proceedings
DIABETOLOGIA
Issue
SUPPL 1
ISSN
0012-186X